Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poly-ICLC in Chronic HIV-1 Infection
NCT02071095Phase 2Completed
- Sponsor
- Nina Bhardwaj
- Start
- Apr 2014
- Primary completion
- Jul 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of poly iclc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Nina Bhardwaj. Started Apr 2014; status: completed.
02
Drugs
poly iclc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02071095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071095.